CN Stock MarketDetailed Quotes

688273 Nanjing Medlander Medical Technology

Watchlist
  • 25.83
  • -0.57-2.16%
Market Closed Dec 13 15:00 CST
2.58BMarket Cap25.52P/E (TTM)

Nanjing Medlander Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
13.81%330.58M
11.73%228.38M
-4.39%104.34M
-9.57%340.82M
-2.64%290.46M
11.61%204.4M
46.34%109.12M
10.32%376.89M
29.36%298.32M
18.83%183.13M
Operating revenue
13.81%330.58M
11.73%228.38M
-4.39%104.34M
-9.57%340.82M
-2.64%290.46M
11.61%204.4M
46.34%109.12M
10.32%376.89M
29.36%298.32M
18.83%183.13M
Total operating cost
5.34%232.3M
-2.64%153.78M
-15.24%67.44M
1.14%275.11M
4.06%220.53M
14.09%157.96M
50.40%79.57M
15.15%272.01M
35.53%211.92M
36.06%138.45M
Operating cost
6.83%91.4M
-4.79%61.66M
-32.73%27.07M
-16.93%98.47M
-13.23%85.56M
-4.83%64.77M
100.86%40.24M
28.15%118.53M
60.09%98.61M
71.31%68.06M
Operating tax surcharges
-14.87%3.07M
-22.89%2.06M
-52.77%519.22K
16.44%4.95M
23.00%3.61M
45.67%2.68M
27.52%1.1M
-13.86%4.25M
-14.60%2.93M
-32.15%1.84M
Operating expense
0.26%66.28M
0.44%44.46M
3.46%19.82M
-1.92%82.53M
6.41%66.11M
15.69%44.27M
9.35%19.15M
14.11%84.14M
33.23%62.13M
27.73%38.26M
Administration expense
15.35%38.26M
11.70%25.25M
10.81%10.89M
38.51%45.31M
44.82%33.17M
63.14%22.6M
48.67%9.82M
15.10%32.72M
17.31%22.91M
10.16%13.85M
Financial expense
31.99%-7.33M
-17.57%-6.07M
-32.26%-3.8M
-60.54%-14.38M
-310.31%-10.78M
-201.60%-5.16M
-317.58%-2.87M
-1,406.77%-8.96M
-560.05%-2.63M
-297,565.44%-1.71M
-Interest expense (Financial expense)
142.89%763.43K
107.29%443.7K
66.73%182.54K
26.59%380.94K
67.33%314.31K
65.81%214.04K
68.75%109.48K
97.07%300.94K
-6.88%187.84K
13.53%129.09K
-Interest Income (Financial expense)
27.01%-8.13M
-21.24%-6.52M
-32.72%-3.99M
-59.75%-14.87M
-377.79%-11.14M
-190.50%-5.38M
-295.70%-3M
-1,092.45%-9.31M
-272.00%-2.33M
-1,293.77%-1.85M
Research and development
-5.23%40.62M
-8.29%26.42M
6.78%12.95M
40.89%58.24M
53.18%42.86M
58.75%28.81M
41.40%12.13M
11.04%41.34M
9.38%27.98M
8.10%18.15M
Credit Impairment Loss
-351.82%-853.14K
-658.02%-998.86K
-116.32%-433K
77.81%-647.63K
85.09%-188.82K
88.05%-131.77K
-43.99%-200.17K
-437.71%-2.92M
-630.82%-1.27M
-819.01%-1.1M
Asset Impairment Loss
----
----
----
-31.11%-457.18K
----
----
----
-106.15%-348.71K
----
----
Other net revenue
Fair value change income
219.71%1.13M
37.29%496.15K
---340.05K
--652.16K
--352.12K
157.93%361.39K
----
----
----
--140.11K
Invest income
-79.56%2.17M
-80.38%1.61M
-71.76%1.36M
74.28%13.89M
158.63%10.63M
532.57%8.19M
1,108.21%4.82M
67.17%7.97M
134.54%4.11M
-21.85%1.3M
-Including: Investment income associates
-60.48%-495.23K
-0.75%-217.1K
26.95%-104.45K
-903.44%-344.22K
-366.39%-308.6K
-240.61%-215.49K
-305.34%-142.99K
37.37%42.84K
-90.91%-66.17K
-195.04%-63.27K
Asset deal income
-6,751.93%-248.24K
----
----
--234.85K
--3.73K
----
----
----
----
238.06%842.15
Other revenue
-23.77%12.9M
-18.71%9.68M
25.69%4.56M
-36.33%23.1M
-41.00%16.92M
0.24%11.91M
36.79%3.63M
79.36%36.28M
96.00%28.68M
3.39%11.88M
Operating profit
16.11%113.37M
27.87%85.39M
11.23%42.05M
-29.74%102.48M
-17.20%97.64M
17.35%66.78M
53.81%37.8M
12.19%145.86M
28.52%117.92M
-12.74%56.91M
Add:Non operating Income
93.49%156.61K
2.22%61.25K
-17.92%10.99K
-15.66%91.76K
-13.94%80.94K
-20.47%59.92K
-55.15%13.39K
709.47%108.8K
599.80%94.06K
595.03%75.34K
Less:Non operating expense
53.20%466.77K
48.80%223.12K
-99.41%34.66
1,458.28%1.1M
4,156.15%304.67K
1,284.89%149.94K
181.39%5.86K
-75.78%70.28K
-97.43%7.16K
-95.89%10.83K
Total profit
16.06%113.06M
27.80%85.23M
11.23%42.06M
-30.44%101.48M
-17.45%97.42M
17.06%66.69M
53.67%37.81M
12.46%145.9M
28.99%118M
-12.30%56.97M
Less:Income tax cost
15.54%12.53M
54.64%9.32M
-12.36%3.87M
-45.83%9M
-8.09%10.85M
7.31%6.03M
111.71%4.42M
65.47%16.61M
-10.70%11.8M
-41.48%5.62M
Net profit
16.13%100.53M
25.13%75.91M
14.36%38.19M
-28.47%92.48M
-18.49%86.57M
18.13%60.66M
48.29%33.39M
8.01%129.29M
35.69%106.2M
-7.25%51.35M
Net profit from continuing operation
16.13%100.53M
25.13%75.91M
14.36%38.19M
-28.47%92.48M
-18.49%86.57M
18.13%60.66M
48.29%33.39M
8.01%129.29M
35.69%106.2M
-7.25%51.35M
Less:Minority Profit
143.46%4.46M
81.51%3.3M
88.74%1.9M
-64.93%2.67M
-77.41%1.83M
-61.13%1.82M
-29.76%1.01M
478.51%7.6M
1,016.57%8.11M
4,917.10%4.68M
Net profit of parent company owners
13.37%96.07M
23.39%72.61M
12.04%36.29M
-26.19%89.82M
-13.62%84.74M
26.08%58.84M
53.60%32.39M
2.79%121.68M
26.51%98.1M
-15.56%46.67M
Earning per share
Basic earning per share
15.19%0.9728
24.97%0.7331
13.00%0.366
-38.49%0.8982
-33.04%0.8445
-5.74%0.5866
15.23%0.3239
-7.49%1.4602
21.98%1.2612
-15.56%0.6223
Diluted earning per share
15.19%0.9728
24.97%0.7331
13.00%0.366
-38.49%0.8982
-33.04%0.8445
-5.74%0.5866
15.23%0.3239
-7.49%1.4602
21.98%1.2612
-15.56%0.6223
Other composite income
Total composite income
16.13%100.53M
25.13%75.91M
14.36%38.19M
-28.47%92.48M
-18.49%86.57M
18.13%60.66M
48.29%33.39M
8.01%129.29M
35.69%106.2M
-7.25%51.35M
Total composite income of parent company owners
13.37%96.07M
23.39%72.61M
12.04%36.29M
-26.19%89.82M
-13.62%84.74M
26.08%58.84M
53.60%32.39M
2.79%121.68M
26.51%98.1M
-15.56%46.67M
Total composite income of minority owners
143.46%4.46M
81.51%3.3M
88.74%1.9M
-64.93%2.67M
-77.41%1.83M
-61.13%1.82M
-29.76%1.01M
478.51%7.6M
1,016.57%8.11M
4,917.10%4.68M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 13.81%330.58M11.73%228.38M-4.39%104.34M-9.57%340.82M-2.64%290.46M11.61%204.4M46.34%109.12M10.32%376.89M29.36%298.32M18.83%183.13M
Operating revenue 13.81%330.58M11.73%228.38M-4.39%104.34M-9.57%340.82M-2.64%290.46M11.61%204.4M46.34%109.12M10.32%376.89M29.36%298.32M18.83%183.13M
Total operating cost 5.34%232.3M-2.64%153.78M-15.24%67.44M1.14%275.11M4.06%220.53M14.09%157.96M50.40%79.57M15.15%272.01M35.53%211.92M36.06%138.45M
Operating cost 6.83%91.4M-4.79%61.66M-32.73%27.07M-16.93%98.47M-13.23%85.56M-4.83%64.77M100.86%40.24M28.15%118.53M60.09%98.61M71.31%68.06M
Operating tax surcharges -14.87%3.07M-22.89%2.06M-52.77%519.22K16.44%4.95M23.00%3.61M45.67%2.68M27.52%1.1M-13.86%4.25M-14.60%2.93M-32.15%1.84M
Operating expense 0.26%66.28M0.44%44.46M3.46%19.82M-1.92%82.53M6.41%66.11M15.69%44.27M9.35%19.15M14.11%84.14M33.23%62.13M27.73%38.26M
Administration expense 15.35%38.26M11.70%25.25M10.81%10.89M38.51%45.31M44.82%33.17M63.14%22.6M48.67%9.82M15.10%32.72M17.31%22.91M10.16%13.85M
Financial expense 31.99%-7.33M-17.57%-6.07M-32.26%-3.8M-60.54%-14.38M-310.31%-10.78M-201.60%-5.16M-317.58%-2.87M-1,406.77%-8.96M-560.05%-2.63M-297,565.44%-1.71M
-Interest expense (Financial expense) 142.89%763.43K107.29%443.7K66.73%182.54K26.59%380.94K67.33%314.31K65.81%214.04K68.75%109.48K97.07%300.94K-6.88%187.84K13.53%129.09K
-Interest Income (Financial expense) 27.01%-8.13M-21.24%-6.52M-32.72%-3.99M-59.75%-14.87M-377.79%-11.14M-190.50%-5.38M-295.70%-3M-1,092.45%-9.31M-272.00%-2.33M-1,293.77%-1.85M
Research and development -5.23%40.62M-8.29%26.42M6.78%12.95M40.89%58.24M53.18%42.86M58.75%28.81M41.40%12.13M11.04%41.34M9.38%27.98M8.10%18.15M
Credit Impairment Loss -351.82%-853.14K-658.02%-998.86K-116.32%-433K77.81%-647.63K85.09%-188.82K88.05%-131.77K-43.99%-200.17K-437.71%-2.92M-630.82%-1.27M-819.01%-1.1M
Asset Impairment Loss -------------31.11%-457.18K-------------106.15%-348.71K--------
Other net revenue
Fair value change income 219.71%1.13M37.29%496.15K---340.05K--652.16K--352.12K157.93%361.39K--------------140.11K
Invest income -79.56%2.17M-80.38%1.61M-71.76%1.36M74.28%13.89M158.63%10.63M532.57%8.19M1,108.21%4.82M67.17%7.97M134.54%4.11M-21.85%1.3M
-Including: Investment income associates -60.48%-495.23K-0.75%-217.1K26.95%-104.45K-903.44%-344.22K-366.39%-308.6K-240.61%-215.49K-305.34%-142.99K37.37%42.84K-90.91%-66.17K-195.04%-63.27K
Asset deal income -6,751.93%-248.24K----------234.85K--3.73K----------------238.06%842.15
Other revenue -23.77%12.9M-18.71%9.68M25.69%4.56M-36.33%23.1M-41.00%16.92M0.24%11.91M36.79%3.63M79.36%36.28M96.00%28.68M3.39%11.88M
Operating profit 16.11%113.37M27.87%85.39M11.23%42.05M-29.74%102.48M-17.20%97.64M17.35%66.78M53.81%37.8M12.19%145.86M28.52%117.92M-12.74%56.91M
Add:Non operating Income 93.49%156.61K2.22%61.25K-17.92%10.99K-15.66%91.76K-13.94%80.94K-20.47%59.92K-55.15%13.39K709.47%108.8K599.80%94.06K595.03%75.34K
Less:Non operating expense 53.20%466.77K48.80%223.12K-99.41%34.661,458.28%1.1M4,156.15%304.67K1,284.89%149.94K181.39%5.86K-75.78%70.28K-97.43%7.16K-95.89%10.83K
Total profit 16.06%113.06M27.80%85.23M11.23%42.06M-30.44%101.48M-17.45%97.42M17.06%66.69M53.67%37.81M12.46%145.9M28.99%118M-12.30%56.97M
Less:Income tax cost 15.54%12.53M54.64%9.32M-12.36%3.87M-45.83%9M-8.09%10.85M7.31%6.03M111.71%4.42M65.47%16.61M-10.70%11.8M-41.48%5.62M
Net profit 16.13%100.53M25.13%75.91M14.36%38.19M-28.47%92.48M-18.49%86.57M18.13%60.66M48.29%33.39M8.01%129.29M35.69%106.2M-7.25%51.35M
Net profit from continuing operation 16.13%100.53M25.13%75.91M14.36%38.19M-28.47%92.48M-18.49%86.57M18.13%60.66M48.29%33.39M8.01%129.29M35.69%106.2M-7.25%51.35M
Less:Minority Profit 143.46%4.46M81.51%3.3M88.74%1.9M-64.93%2.67M-77.41%1.83M-61.13%1.82M-29.76%1.01M478.51%7.6M1,016.57%8.11M4,917.10%4.68M
Net profit of parent company owners 13.37%96.07M23.39%72.61M12.04%36.29M-26.19%89.82M-13.62%84.74M26.08%58.84M53.60%32.39M2.79%121.68M26.51%98.1M-15.56%46.67M
Earning per share
Basic earning per share 15.19%0.972824.97%0.733113.00%0.366-38.49%0.8982-33.04%0.8445-5.74%0.586615.23%0.3239-7.49%1.460221.98%1.2612-15.56%0.6223
Diluted earning per share 15.19%0.972824.97%0.733113.00%0.366-38.49%0.8982-33.04%0.8445-5.74%0.586615.23%0.3239-7.49%1.460221.98%1.2612-15.56%0.6223
Other composite income
Total composite income 16.13%100.53M25.13%75.91M14.36%38.19M-28.47%92.48M-18.49%86.57M18.13%60.66M48.29%33.39M8.01%129.29M35.69%106.2M-7.25%51.35M
Total composite income of parent company owners 13.37%96.07M23.39%72.61M12.04%36.29M-26.19%89.82M-13.62%84.74M26.08%58.84M53.60%32.39M2.79%121.68M26.51%98.1M-15.56%46.67M
Total composite income of minority owners 143.46%4.46M81.51%3.3M88.74%1.9M-64.93%2.67M-77.41%1.83M-61.13%1.82M-29.76%1.01M478.51%7.6M1,016.57%8.11M4,917.10%4.68M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------------
Auditor ------Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme The Concept of Three Children
The Concept of Three Children
Intraday-1.57%
Specialized, Special and New
Specialized, Special and New
Intraday-1.91%